Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 2,104,745 | 1,378,477 | 445,824 | 459,074 | 379,268 |
| Cost of Goods | 155,355 | 84,455 | 4,216 | 2,093 | 1,686 |
| Gross Profit | 1,949,390 | 1,294,022 | 441,608 | 456,981 | 377,582 |
| Operating Expenses | 1,206,695 | 836,764 | 646,983 | 554,546 | 452,371 |
| Operating Income | 743,050 | 457,713 | -205,159 | -97,472 | -74,103 |
| Interest Expense | 46,437 | 45,304 | 21,282 | 9,118 | 2,337 |
| Other Income | -231 | 2,012 | 3,549 | 2,122 | 4,488 |
| Pre-tax Income | 696,382 | 414,421 | -222,892 | -104,468 | -71,952 |
| Income Tax | 282,644 | -335,848 | -1,132 | N/A | -4,122 |
| Net Income Continuous | 413,738 | 750,269 | -221,760 | -104,468 | -67,830 |
| Net Income | $413,738 | $750,269 | $-221,760 | $-104,468 | $-67,830 |
| EPS Basic Total Ops | 4.23 | 7.92 | -2.45 | -1.26 | -0.85 |
| EPS Basic Continuous Ops | 4.23 | 7.92 | -2.45 | -1.26 | -0.85 |
| EPS Diluted Total Ops | 3.72 | 6.75 | -2.45 | -1.26 | -0.85 |
| EPS Diluted Continuous Ops | 3.72 | 6.50 | -2.45 | -1.26 | -0.85 |
| EBITDA(a) | $784,254 | $494,653 | $-174,077 | $-77,785 | $-59,856 |